Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Harvard Business School
Federal Trade Commission
Merck
Express Scripts
Moodys
Fuji
Accenture
Farmers Insurance

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040668

« Back to Dashboard

NDA 040668 describes CYPROHEPTADINE HYDROCHLORIDE, which is a drug marketed by Actavis Mid Atlantic, Bio-pharm Inc, Halsey, Lannett Co Inc, Lyne, Morton Grove, Naska, Pharm Assoc, Am Therap, Apex Pharms Inc, Apnar Pharma Lp, Appco Pharma Llc, Ascot, Chartwell Rx, Duramed Pharms Barr, Fosun Pharma, Ingenus Pharms Nj, Ivax Sub Teva Pharms, Kv Pharm, Md Pharm, Mountain, Mylan, Par Pharm, Pioneer Pharms, Pliva, Santos Biotech, Strides Pharma, Superpharm, Vitarine, Watson Labs, and Zydus Pharms Usa Inc, and is included in thirty-four NDAs. It is available from twenty-eight suppliers. Additional details are available on the CYPROHEPTADINE HYDROCHLORIDE profile page.

The generic ingredient in CYPROHEPTADINE HYDROCHLORIDE is cyproheptadine hydrochloride. There are six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the cyproheptadine hydrochloride profile page.
Summary for 040668
Tradename:CYPROHEPTADINE HYDROCHLORIDE
Applicant:Lyne
Ingredient:cyproheptadine hydrochloride
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 040668
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride SYRUP;ORAL 040668 ANDA Actavis Pharma, Inc. 0472-1400 N 0472-1400-16
CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride SYRUP;ORAL 040668 ANDA Physicians Total Care, Inc. 54868-4338 E 54868-4338-0

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYRUP;ORALStrength2MG/5ML
Approval Date:Jun 28, 2006TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
Colorcon
Accenture
Baxter
Merck
Mallinckrodt
Citi
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.